← Back to Search

Ketorolac for Acute Pancreatitis

Phase 4
Waitlist Available
Led By Anthony J Gentene, PharmD
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during hospital admission
Awards & highlights

Study Summary

This trial will compare different ways of managing pain for people hospitalized with acute pancreatitis.

Eligible Conditions
  • Acute Pancreatitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 to day 5 of study
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 to day 5 of study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Opioids
Secondary outcome measures
Morphine
Duration of intravenous opioid use

Trial Design

2Treatment groups
Active Control
Group I: Standard of CareActive Control1 Intervention
Patients receiving standard of care pain management including opioids.
Group II: KetorolacActive Control1 Intervention
Patients will receive standard of care pain management plus intravenous ketorolac.

Find a Location

Who is running the clinical trial?

University of CincinnatiLead Sponsor
427 Previous Clinical Trials
634,302 Total Patients Enrolled
Anthony J Gentene, PharmDPrincipal InvestigatorUniversity of Cincinnati

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~12 spots leftby Apr 2025